# Abbott Laboratories nutrition business spin-off > Live situation record from CLSTR: https://clstr.news/situations/abbott-laboratories-nutrition-business-spin-off > Updated: 2026-10-24T11:42:57.000Z. Sources: 7. Developments: 2. Abbott Laboratories has announced plans to spin off its nutrition division into an independent, publicly traded company, a process expected to be completed by the end of 2027. The nutrition unit, which includes brands such as Similac, Ensure, and Pedialyte, generates approximately $8.5 billion in annual sales and employs roughly 16,000 people. The separation is intended to allow Abbott to focus on higher-growth sectors, including medical devices, diagnostics, biowearables, and pharmaceuticals. Daniel Salvadori is slated to become the CEO of the new standalone entity. The decision follows a period of challenges for the nutrition division, including a 2022 baby formula recall, a manufacturing plant shutdown in Sturgis, Michigan, and significant legal liabilities related to infant formula products. Following the announcement, Abbott lowered its 2026 sales growth forecast to approximately 6% and tightened its full-year adjusted profit per share forecast. ## Timeline ### 2026-10-24: Abbott Laboratories to spin off nutrition division Abbott Laboratories will spin off its $8.5 billion nutrition division into an independent company by 2027, following legal challenges and a reduced sales growth forecast. 3 sources. https://clstr.news/cluster/abbott-laboratories-to-spin-off-nutrition-division ### 2026-10-21: Abbott Laboratories to spin off $8.5 billion nutrition business Abbott Laboratories will spin off its $8.5 billion nutrition business into an independent public company by late 2027 to focus on medical devices, diagnostics, and pharmaceuticals. 4 sources. https://clstr.news/cluster/abbott-laboratories-to-spin-off-85-billion-nutrition-business --- Cite as: Abbott Laboratories nutrition business spin-off. CLSTR, https://clstr.news/situations/abbott-laboratories-nutrition-business-spin-off